Literature DB >> 25594456

Broad and strong: the ultimate antibody to dengue virus.

Josefina Coloma1, Eva Harris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25594456     DOI： 10.1038/ni.3081

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  15 in total

1.  The structural basis for serotype-specific neutralization of dengue virus by a human antibody.

Authors:  Ee Ping Teoh; Petra Kukkaro; En Wei Teo; Angeline P C Lim; Tze Tong Tan; Andy Yip; Wouter Schul; Myint Aung; Victor A Kostyuchenko; Yee Sin Leo; Soh Ha Chan; Kenneth G C Smith; Annie Hoi Yi Chan; Gang Zou; Eng Eong Ooi; D Michael Kemeny; Grace K Tan; Jowin K W Ng; Mah Lee Ng; Sylvie Alonso; Dale Fisher; Pei-Yong Shi; Brendon J Hanson; Shee-Mei Lok; Paul A MacAry
Journal:  Sci Transl Med       Date:  2012-06-20       Impact factor: 17.956

2.  Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Authors:  Mickaël V Cherrier; Bärbel Kaufmann; Grant E Nybakken; Shee-Mei Lok; Julia T Warren; Beverly R Chen; Christopher A Nelson; Victor A Kostyuchenko; Heather A Holdaway; Paul R Chipman; Richard J Kuhn; Michael S Diamond; Michael G Rossmann; Daved H Fremont
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

3.  Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

Authors:  Ruklanthi de Alwis; Scott A Smith; Nicholas P Olivarez; William B Messer; Jeremy P Huynh; Wahala M P B Wahala; Laura J White; Michael S Diamond; Ralph S Baric; James E Crowe; Aravinda M de Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-12       Impact factor: 11.205

4.  Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.

Authors:  Scott A Smith; Yang Zhou; Nicholas P Olivarez; Anne H Broadwater; Aravinda M de Silva; James E Crowe
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.

Authors:  Meihui Xu; Vey Hadinoto; Ramapraba Appanna; Klas Joensson; Ying Xiu Toh; Thavamalar Balakrishnan; Swee Hoe Ong; Lucile Warter; Yee Sin Leo; Cheng-I Wang; Katja Fink
Journal:  J Immunol       Date:  2012-11-14       Impact factor: 5.422

6.  The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Authors:  Scott A Smith; A Ruklanthi de Alwis; Nurgun Kose; Eva Harris; Kristie D Ibarra; Kristen M Kahle; Jennifer M Pfaff; Xiaoxiao Xiang; Benjamin J Doranz; Aravinda M de Silva; S Kyle Austin; Soila Sukupolvi-Petty; Michael S Diamond; James E Crowe
Journal:  mBio       Date:  2013-11-19       Impact factor: 7.867

7.  High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Authors:  Wen-Yang Tsai; Chih-Yun Lai; Yi-Chieh Wu; Hong-En Lin; Carolyn Edwards; Amonrat Jumnainsong; Srisakul Kliks; Scott Halstead; Juthathip Mongkolsapaya; Gavin R Screaton; Wei-Kung Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

8.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Authors:  Wanwisa Dejnirattisai; Wiyada Wongwiwat; Sunpetchuda Supasa; Xiaokang Zhang; Xinghong Dai; Alexander Rouvinski; Amonrat Jumnainsong; Carolyn Edwards; Nguyen Than Ha Quyen; Thaneeya Duangchinda; Jonathan M Grimes; Wen-Yang Tsai; Chih-Yun Lai; Wei-Kung Wang; Prida Malasit; Jeremy Farrar; Cameron P Simmons; Z Hong Zhou; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2014-12-15       Impact factor: 25.606

9.  The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

Authors:  Laura A VanBlargan; Swati Mukherjee; Kimberly A Dowd; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

10.  A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.

Authors:  Guntur Fibriansah; Joanne L Tan; Scott A Smith; Adamberage R de Alwis; Thiam-Seng Ng; Victor A Kostyuchenko; Kristie D Ibarra; Jiaqi Wang; Eva Harris; Aravinda de Silva; James E Crowe; Shee-Mei Lok
Journal:  EMBO Mol Med       Date:  2014-01-13       Impact factor: 12.137
View more
  7 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

2.  Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.

Authors:  Graham Simmons; Mars Stone; Michael P Busch
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

3.  Target Identification Using Homopharma and Network-Based Methods for Predicting Compounds Against Dengue Virus-Infected Cells.

Authors:  Kowit Hengphasatporn; Kitiporn Plaimas; Apichat Suratanee; Peemapat Wongsriphisant; Jinn-Moon Yang; Yasuteru Shigeta; Warinthorn Chavasiri; Siwaporn Boonyasuppayakorn; Thanyada Rungrotmongkol
Journal:  Molecules       Date:  2020-04-18       Impact factor: 4.411

4.  Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.

Authors:  Yanling Wu; Shun Li; Lanying Du; Chunyu Wang; Peng Zou; Binbin Hong; Mengjiao Yuan; Xiaonan Ren; Wanbo Tai; Yu Kong; Chen Zhou; Lu Lu; Xiaohui Zhou; Shibo Jiang; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2017-10-11       Impact factor: 7.163

5.  Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.

Authors:  Emily N Gallichotte; Thomas J Baric; Boyd L Yount; Douglas G Widman; Anna Durbin; Steve Whitehead; Ralph S Baric; Aravinda M de Silva
Journal:  PLoS Pathog       Date:  2018-02-26       Impact factor: 6.823

6.  Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization.

Authors:  Emily N Gallichotte; Thomas J Baric; Usha Nivarthi; Matthew J Delacruz; Rachel Graham; Douglas G Widman; Boyd L Yount; Anna P Durbin; Stephen S Whitehead; Aravinda M de Silva; Ralph S Baric
Journal:  Cell Rep       Date:  2018-10-30       Impact factor: 9.423

Review 7.  Humanized Mice in Dengue Research: A Comparison with Other Mouse Models.

Authors:  Carolina Coronel-Ruiz; Hernando Gutiérrez-Barbosa; Sandra Medina-Moreno; Myriam L Velandia-Romero; Joel V Chua; Jaime E Castellanos; Juan C Zapata
Journal:  Vaccines (Basel)       Date:  2020-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.